Zobrazeno 1 - 10
of 126
pro vyhledávání: '"NEDA RASOULI"'
Autor:
Samuel Dagogo-Jack, Erin S LeBlanc, Richard E Pratley, Neda Rasouli, Anastassios G Pittas, Jason Nelson, Ranee Chatterjee, Mary K Rhee, Cyrus V Desouza, Lisa M Neff, Anne M Peters, Daniel S Hsia
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 1 (2024)
Introduction Understanding how race may influence the association between A1c and glycemia can improve diabetes screening. We sought to determine whether, for a given A1c level, glucose levels during an oral glucose tolerance test (OGTT) differed by
Externí odkaz:
https://doaj.org/article/0df00ff608434434bc5c16c8f644e811
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 14 (2023)
Objective: To describe the rationale and design of the SIB trial, an interventional clinical trial testing the hypothesis that subcutaneous (s.c.) once-weekly semaglutide can improve intestinal permeability and reduce systemic inflammation in partici
Externí odkaz:
https://doaj.org/article/a01c6dbdc4e649c08f3d2fd0c57df0e3
Autor:
Mustafa Tosur, Laura Gandolfo, Ashok Balasubramanyam, Rochelle N. Naylor, Toni I. Pollin, Neda Rasouli, Sara J. Cromer, John B. Buse, Maria J. Redondo, RADIANT Study Group
Publikováno v:
Journal of Clinical and Translational Science, Vol 7 (2023)
Abstract Introduction: Diabetes mellitus in underrepresented racial and ethnic groups (URG) is rapidly increasing in incidence and has worse outcomes than diabetes in non-Hispanic White individuals. Rare and Atypical Diabetes Network (RADIANT) estab
Externí odkaz:
https://doaj.org/article/909e7188a55f47e3b112de37f19c358e
Autor:
Mohammad Javad Zibaeenezhad, Mehrab Sayadi, Seyyed Saeed Mohammadi, Soorena Khorshidi, Ehsan Hadiyan, Neda Rasouli, Ali Karimi-Akhormeh, Iman Razeghian-Jahromi
Publikováno v:
Journal of Tehran University Heart Center, Vol 17, Iss 4 (2022)
Background: This study aimed to investigate the possible relationship between different stent sizes and clinical outcomes after percutaneous coronary intervention (PCI) in patients with diabetes treated with drug-eluting stents (DESs) and dual antipl
Externí odkaz:
https://doaj.org/article/81a7ecf984964af880f31458c52aeff6
Autor:
C Wright, C Sanders, C Wilson, L Tucker, S Jones, S Douglass, C Patel, A Kumar, S Smith, C Adams, R Hill, D Martin, M Lee, J Cook, M Jackson, G Riera, E González, J Park, S Yang, A Carlson, C Martin, A Krol, A Sood, J Martinez, C DeSouza, M Johnson, L Estrada, A Jackson, K Martin, SA Khan, J Craig, A Kuhn, Deborah J Wexler, R Chatterjee, J Kerr, W Taylor, R Henry, R Fraser, Kieren J Mather, M Larkin, E King, E Diaz, J Marks, A Ross, M Khalid, J Barzilay, B Chambers, G Montes, C Jensen, J McConnell, R Nelson, S Morton, M Curtis, P Wilson, L Young, M Fürst, C Newman, S Kuo, N Rasouli, A Werner, A Ghazi, F Ismail-Beigi, P Kringas, C Baker, E Ellis, Philip Raskin, A Cherian, L Holloway, M Madden, B Hollis, G Fuller, B Steiner, K Stokes, T Lowe, K Chu, S Durán, A Alfred, John M Lachin, T Hamilton, J Costello, E Burgess, R Garg, C Stevens, T Tran, M Hurtado, H Schneier, R Lorch, M Mullen, J Bantle, K Arnold, D Wexler, Neda Rasouli, D Howard, J Tejada, S Hernandez, E Schroeder, S Kunkel, G Lord, A Smiley, E Debnam, H Petrovitch, B Kauffman, V Jenkins, B Cramer, Kristina M Utzschneider, Naji Younes, Joshua I Barzilay, Mary Ann Banerji, Robert M Cohen, Erica V Gonzalez, Faramarz Ismail-Beigi, Steven E Kahn, JP Crandall, MD McKee, S Behringer-Massera, J Brown-Friday, E Xhori, K Ballentine-Cargill, H Estrella, S Gonzalez de la torre, J Lukin, LS Phillips, D Olson, M Rhee, TS Raines, J Boers, C Gullett, M Maher-Albertelli, R Mungara, L Savoye, CA White, F Morehead, S Person, M Sibymon, S Tanukonda, A Balasubramanyam, R Gaba, P Hollander, E Roe, P Burt, K Chionh, C Falck-Ytter, L Sayyed Kassem, M Tiktin, T Kulow, KA Stancil, J Iacoboni, MV Kononets, G McPhee AMaxwell, L Colosimo, R Goland, J Pring, L Alfano, C Hausheer, K Gumpel, A Kirpitch, JB Green, H AbouAssi, MN Feinglos, J English Jones, RP Zimmer, BM Satterwhite, K Evans Kreider, CR Thacker, CN Mariash, KJ Mather, A Lteif, V Pirics, D Aguillar, S Hurt, R Bergenstal, T Martens, J Hyatt, H Willis, W Konerza, K Kleeberger, R Passi, S Fortmann, M Herson, K Mularski, H Glauber, J Prihoda, B Ash, C Carlson, PA Ramey, E Schield, B Torgrimson-Ojerio, E Panos, S Sahnow, K Bays, K Berame, D Ghioni, J Gluth, K Schell, J Criscola, C Friason, S Nazarov, N Rassouli, R Puttnam, B Ojoawo, C Sanders-Jones, Z El-Haqq, A Kolli, J Meigs, A Dushkin, G Rocchio, M Yepes, H Dulin, M Cayford, A DeManbey, M Hillard, N Thangthaeng, L Gurry, R Kochis, E Raymond, V Ripley, V Aroda, Ann Ressing, A Loveland, M Hamm, F Mofor, HJ Florez, WM Valencia, S Casula, L Oropesa-Gonzalez, L Hue, AK Riccio Veliz, R Nieto-Martinez, M Gutt, A Ahmann, D Aby-Daniel, F Joarder, V Morimoto, C Sprague, D Yamashita, N Cady, N Rivera-Eschright, P Kirchhoff, B Morales Gomez, J Adducci, A Goncharova, SH Hox, M Matwichyna, NO Bermudez, L Broadwater, RR Ishii, DS Hsia, WT Cefalu, FL Greenway, C Waguespack, N Haynes, A Thomassie, B Bourgeois, C Hazlett, S Mudaliar, S Boeder, J Pettus, D Garcia-Acosta, S Maggs, C DeLue, E Castro, J Krakoff, JM Curtis, T Killean, E Joshevama, K Tsingine, T Karshner, J Albu, FX Pi-Sunyer, S Frances, C Maggio, J Bastawrose, X Gong, MA Banerji, D Lorber, NM Brown, DH Josephson, LL Thomas, M Tsovian, MH Jacobson, MM Mishko, MS Kirkman, JB Buse, J Dostou, K Bergamo, A Goley, JF Largay, S Guarda, J Cuffee, D Culmer, H Almeida, S Coffer, L Kiker, K Josey, WT Garvey, A Cherrington, D Golson, MC Robertson, A Agne, S McCullars, RM Cohen, MC Rogge, K Kersey, S Lipp, MB Vonder Meulen, C Underkofler, S Steiner, W Sivitz, E Cline, L Knosp, WH Herman, R Pop-Busui, MH Tan, A Waltje, A Katona, L Goodhall, R Eggleston, K Whitley, S Bule, N Kessler, E LaSalle, ER Seaquist, A Bantle, T Harindhanavudhi, B Redmon, M Coe, M Mech, A Taddese, L Lesne, L Kuechenmeister, V Shivaswamy, AL Morales, K Seipel, J Eggert, R Tillson, DS Schade, A Adolphe, M Burge, E Duran-Valdez, P August, MG Rodriguez, JB Kimpel, O Griffith
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/cc3fcb77f7be4e7f9a6223e8d48647c4
Publikováno v:
چشمانداز مدیریت صنعتی, Vol 8, Iss 4, Pp 185-212 (2019)
The main aim of this research is to asses contributing factors in supply chain competitiveness in rubber industry. To this point, first, using the extended review in literature of competitiveness, components were identified and conceptual model of re
Externí odkaz:
https://doaj.org/article/a0f23b92a04f4e37a26c26d907bd44ea
Autor:
Chelsea Baker, Cimmaron Retzik-Stahr, Vatsala Singh, Renee Plomondon, Victoria Anderson, Neda Rasouli
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Metformin is a biguanide that is used as first-line treatment of type 2 diabetes mellitus and is effective as monotherapy and in combination with other glucose-lowering medications. It is generally well-tolerated with minimal side effects and is affo
Externí odkaz:
https://doaj.org/article/e9fb9019e7cb4f81a8e128d91994b994
Autor:
Chhavi Chadha, Anastassios G. Pittas, Christine W. Lary, William C. Knowler, Ranee Chatterjee, Lawrence S. Phillips, Vanita R. Aroda, Michael R. Lewis, Richard Pratley, Myrlene A. Staten, Jason Nelson, Neda Rasouli, Irwin Brodsky
Publikováno v:
Metabolism Open, Vol 6, Iss , Pp 100031- (2020)
Aims: To assess whether meeting both fasting plasma glucose (FPG) and HbA1c criteria for prediabetes in people at high risk indicates with near certainty the presence of dysglycemia on repeat testing. Methods: Observational study using data from Vita
Externí odkaz:
https://doaj.org/article/0b41e4074a8a4235baf6cedc6c866c25
Autor:
Daniel A. Kelmenson MD, Kelsey Burr MD, Yusra Azhar MBBS, Paul Reynolds PharmD, BCPS, Chelsea A. Baker MS, MPAS, Neda Rasouli MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 5 (2017)
Sodium-glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control by a reversible inhibition of the sodium-glucose cotransporters in the renal proximal tubules resulting in increased urinary glucose. This unique mechanism, independent of ins
Externí odkaz:
https://doaj.org/article/3f1e6259e0b3449294e74fbe18164f14
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 4 (2016)
Hemoglobin A1c (A1c) is used frequently to diagnose and treat diabetes mellitus. Therefore, it is important be aware of factors that may interfere with the accuracy of A1c measurements. This is a case of a rare hemoglobin variant that falsely elevate
Externí odkaz:
https://doaj.org/article/dedefa133b87403faaf2acb6e2b2267c